130 related articles for article (PubMed ID: 19502117)
1. Intestinal permeability in patients with chronic liver diseases: Its relationship with the aetiology and the entity of liver damage.
Cariello R; Federico A; Sapone A; Tuccillo C; Scialdone VR; Tiso A; Miranda A; Portincasa P; Carbonara V; Palasciano G; Martorelli L; Esposito P; Cartenì M; Del Vecchio Blanco C; Loguercio C
Dig Liver Dis; 2010 Mar; 42(3):200-4. PubMed ID: 19502117
[TBL] [Abstract][Full Text] [Related]
2. Leaky gut in alcoholic cirrhosis: a possible mechanism for alcohol-induced liver damage.
Keshavarzian A; Holmes EW; Patel M; Iber F; Fields JZ; Pethkar S
Am J Gastroenterol; 1999 Jan; 94(1):200-7. PubMed ID: 9934756
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6, nitric oxide, and the clinical and hemodynamic alterations of patients with liver cirrhosis.
Genesca J; Gonzalez A; Segura R; Catalan R; Marti R; Varela E; Cadelina G; Martinez M; Lopez-Talavera JC; Esteban R; Groszmann RJ; Guardia J
Am J Gastroenterol; 1999 Jan; 94(1):169-77. PubMed ID: 9934750
[TBL] [Abstract][Full Text] [Related]
4. Intestinal permeability is increased in patients with advanced cirrhosis.
Pascual S; Such J; Esteban A; Zapater P; Casellas JA; Aparicio JR; Girona E; Gutiérrez A; Carnices F; Palazón JM; Sola-Vera J; Pérez-Mateo M
Hepatogastroenterology; 2003; 50(53):1482-6. PubMed ID: 14571769
[TBL] [Abstract][Full Text] [Related]
5. Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation.
Arkenau HT; Stichtenoth DO; Frölich JC; Manns MP; Böker KH
Z Gastroenterol; 2002 Nov; 40(11):907-13. PubMed ID: 12436367
[TBL] [Abstract][Full Text] [Related]
6. Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.
Reiberger T; Ferlitsch A; Payer BA; Mandorfer M; Heinisch BB; Hayden H; Lammert F; Trauner M; Peck-Radosavljevic M; Vogelsang H;
J Hepatol; 2013 May; 58(5):911-21. PubMed ID: 23262249
[TBL] [Abstract][Full Text] [Related]
7. [Intestinal permeability in alcoholic patients without liver damage].
Hirsch S; Cháves G; Gotteland M; de la Maza P; Petermann M; Barrera P; Bunout D
Rev Med Chil; 1997 Jun; 125(6):653-8. PubMed ID: 9515283
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide in patients with chronic liver diseases.
Pârvu AE; Negrean V; Pleşca-Manea L; Cosma A; Drăghici A; Uifălean A; Moldovan R
Rom J Gastroenterol; 2005 Sep; 14(3):225-30. PubMed ID: 16200231
[TBL] [Abstract][Full Text] [Related]
9. Intestinal permeability increases with the severity of abdominal trauma: a comparison between gas liquid chromatographic and enzymatic method.
Liverani E; Silveri NG; Gasbarrini G; Mingrone G
Hepatogastroenterology; 2000; 47(34):1037-41. PubMed ID: 11020873
[TBL] [Abstract][Full Text] [Related]
10. Early gut mucosal dysfunction in patients with acute pancreatitis.
Liu H; Li W; Wang X; Li J; Yu W
Pancreas; 2008 Mar; 36(2):192-6. PubMed ID: 18376312
[TBL] [Abstract][Full Text] [Related]
11. Allopurinol, oxidative stress and intestinal permeability in patients with cirrhosis: an open-label pilot study.
Spahr L; Bresson-Hadni S; Amann P; Kern I; Golaz O; Frossard JL; Hadengue A
Liver Int; 2007 Feb; 27(1):54-60. PubMed ID: 17241381
[TBL] [Abstract][Full Text] [Related]
12. Alterations in tumor necrosis factor-alpha, interferon-gamma, and interleukin-6 production by natural killer cell-enriched peripheral blood mononuclear cells in chronic alcoholism: relationship with liver disease and ethanol intake.
Laso FJ; Lapeña P; Madruga JI; San Miguel JF; Orfao A; Iglesias MC; Alvarez-Mon M
Alcohol Clin Exp Res; 1997 Oct; 21(7):1226-31. PubMed ID: 9347083
[TBL] [Abstract][Full Text] [Related]
13. Lactulose/mannitol test has high efficacy for excluding organic causes of chronic diarrhea.
Di Leo V; D'Incà R; Diaz-Granado N; Fries W; Venturi C; D'Odorico A; Martines D; Sturniolo GC
Am J Gastroenterol; 2003 Oct; 98(10):2245-52. PubMed ID: 14572575
[TBL] [Abstract][Full Text] [Related]
14. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
Koruk M; Onuk MD; Akçay F; Savas MC
Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
[TBL] [Abstract][Full Text] [Related]
15. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis.
Brun P; Castagliuolo I; Di Leo V; Buda A; Pinzani M; Palù G; Martines D
Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G518-25. PubMed ID: 17023554
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor-alpha levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores.
Kiki I; Yilmaz O; Erdem F; Gundogdu M; Demircan B; Bilici M
Int J Clin Pract; 2006 Sep; 60(9):1075-9. PubMed ID: 16939549
[TBL] [Abstract][Full Text] [Related]
17. Cholelithiasis in patients with chronic active liver disease: evaluation of risk factors.
Castellano L; De Sio I; Silvestrino F; Marmo R; Del Vecchio Blanco C
Ital J Gastroenterol; 1995; 27(8):425-9. PubMed ID: 8775468
[TBL] [Abstract][Full Text] [Related]
18. Nitric oxide and renal functions in liver cirrhosis.
Türkay C; Yönem O; Arikan O; Baskin E
Turk J Gastroenterol; 2004 Jun; 15(2):73-6. PubMed ID: 15334313
[TBL] [Abstract][Full Text] [Related]
19. The role of the gut barrier function in the pathophysiology of viral liver cirrhosis.
Choi Y; Jeon WK; Hwang SJ; Kim BI; Sohn CI; Park DI; Cho YK; Kim HJ; Park JH
Hepatogastroenterology; 2011; 58(109):1244-7. PubMed ID: 21937387
[TBL] [Abstract][Full Text] [Related]
20. Sugar tests detect celiac disease among first-degree relatives.
Smecuol E; Vazquez H; Sugai E; Niveloni S; Pedreira S; Cabanne A; Fiorini A; Kogan Z; Mauriño E; Meddings J; Bai JC
Am J Gastroenterol; 1999 Dec; 94(12):3547-52. PubMed ID: 10606317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
